Maurice Biendo
Maurice Biendo has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Brigitte Canarelli
Laboratoire de Bactériologie, CHU SUD d'Amiens, Centre de Biologie Humaine, Salouël, Amiens, France
4 shared publicationsFlorence Rousseau
Laboratoire de Bactériologie, CHU SUD d'Amiens, Centre de Biologie Humaine, Salouël, Amiens, France
4 shared publicationsFrançois Eb
4 shared publications- Sandrine Castelain
Virology Department, Amiens-Picardie University Hospital, Amiens, France; AGIR Laboratory UR 4294, Jules Verne University of Picardie, Amiens, France
4 shared publications F. Eb
Service de Bactériologie
3 shared publicationsF. Rousseau
Service de Bactériologie
3 shared publications
Latest Publications
- Open Access
- 1 October 2013
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 51 (10) , 3183-3191
Comparison of Xpert MRSA/SA Nasal and MRSA/SA ELITe MGB Assays for Detection of the mecA Gene with Susceptibility Testing Methods for Determination of Methicillin Resistance in Staphylococcus aureus Isolates
In a series of 82 Staphylococcus strains isolated from culture, 100% were identified as Staphylococcus aureus by matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS); 99.9% (77/82) of them were resistant to benzylpenicillin, oxacillin, and cefoxitin, and 6.1% (5/82) were susceptible to methicillin. Xpert MRSA/SA assay results were concordant with the phenotypic results in 76.8% (63/82) of cases and discordant in 23.2% (19/82) of cases. The MRSA/SA ELITe MGB kit results were concordant with phenotypic results in 100% of the cases. When comparing the Xpert MRSA/SA assay results with the MRSA/SA ELITe MGB kit results, 78% (64/82) of the cases were concordant, while 22% (18/82) of the cases were discordant. No statistically significant differences were observed between the two techniques. The PCR protocol that was used to validate the results of these two methods gave the following results: 49 were conventional methicillin-resistant S. aureus (MRSA) isolates ( mecA positive and mecA LGA251 negative), and 25 were phenotypic MRSA isolates ( mecA negative and mecA LGA251 positive).
- 1 October 2013
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 51 (10) , 3183-3191
Open AccessComparison of Xpert MRSA/SA Nasal and MRSA/SA ELITe MGB Assays for Detection of the mecA Gene with Susceptibility Testing Methods for Determination of Methicillin Resistance in Staphylococcus aureus Isolates
In a series of 82 Staphylococcus strains isolated from culture, 100% were identified as Staphylococcus aureus by matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS); 99.9% (77/82) of them were resistant to benzylpenicillin, oxacillin, and cefoxitin, and 6.1% (5/82) were susceptible to methicillin. Xpert MRSA/SA assay results were concordant with the phenotypic results in 76.8% (63/82) of cases and discordant in 23.2% (19/82) of cases. The MRSA/SA ELITe MGB kit results were concordant with phenotypic results in 100% of the cases. When comparing the Xpert MRSA/SA assay results with the MRSA/SA ELITe MGB kit results, 78% (64/82) of the cases were concordant, while 22% (18/82) of the cases were discordant. No statistically significant differences were observed between the two techniques. The PCR protocol that was used to validate the results of these two methods gave the following results: 49 were conventional methicillin-resistant S. aureus (MRSA) isolates ( mecA positive and mecA LGA251 negative), and 25 were phenotypic MRSA isolates ( mecA negative and mecA LGA251 positive).
- 1 February 2013
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 75 (2) , 139-143
Value of Xpert MRSA/SA blood culture assay on the Gene Xpert® Dx System for rapid detection of Staphylococcus aureus and coagulase-negative staphylococci in patients with staphylococcal bacteremia
- 1 February 2013
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 75 (2) , 139-143
Value of Xpert MRSA/SA blood culture assay on the Gene Xpert® Dx System for rapid detection of Staphylococcus aureus and coagulase-negative staphylococci in patients with staphylococcal bacteremia
- Open Access
- 31 October 2010
- Published by Hindawi Limited in International Journal of Microbiology
- Vol. 2010, 1-8
Molecular Characterization of Glycopeptide-Resistant Enterococci from Hospitals of the Picardy Region (France)
We studied 138 glycopeptide-resistant enterococci (GRE) strains, consisting of 131 glycopeptide-resistantEnterococcus faecium(GREfm) and 7 glycopeptide-resistantEnterococcus faecalis(GREfs). The GREfm strains were resistant to penicillin, ampicillin, vancomycin, and teicoplanin, while the GREfs strains were only resistant to vancomycin and teicoplanin. Thevan Agene was the only glycopeptide determinant present in all GRE isolates investigated. Genes coding for Hyl and Hyl+ Esp were detected in 39 (29.8%) and 92 (70.2%) of the 131 GREfm isolates, respectively. Three of the 7 GREfs were positive forgelE+asa 1genes, 3 forgel Egene, and 1 forasa 1gene. The genetic relationship between the 138 GRE was analyzed by pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST). GREfm isolates were clustered in a single genogroup (pulsotype A), and GREfs were clustered in six genogroups (pulsotypes B-G). Among the isolates investigated by MLST, only 18 PCR products were sequenced (12E. faeciumand 6E. faecalis), and 9 sequence types (STs) were identified.
- 31 October 2010
- Published by Hindawi Limited in International Journal of Microbiology
- Vol. 2010, 1-8
Open AccessMolecular Characterization of Glycopeptide-Resistant Enterococci from Hospitals of the Picardy Region (France)
We studied 138 glycopeptide-resistant enterococci (GRE) strains, consisting of 131 glycopeptide-resistantEnterococcus faecium(GREfm) and 7 glycopeptide-resistantEnterococcus faecalis(GREfs). The GREfm strains were resistant to penicillin, ampicillin, vancomycin, and teicoplanin, while the GREfs strains were only resistant to vancomycin and teicoplanin. Thevan Agene was the only glycopeptide determinant present in all GRE isolates investigated. Genes coding for Hyl and Hyl+ Esp were detected in 39 (29.8%) and 92 (70.2%) of the 131 GREfm isolates, respectively. Three of the 7 GREfs were positive forgelE+asa 1genes, 3 forgel Egene, and 1 forasa 1gene. The genetic relationship between the 138 GRE was analyzed by pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST). GREfm isolates were clustered in a single genogroup (pulsotype A), and GREfs were clustered in six genogroups (pulsotypes B-G). Among the isolates investigated by MLST, only 18 PCR products were sequenced (12E. faeciumand 6E. faecalis), and 9 sequence types (STs) were identified.
- 1 November 2008
- Published by Elsevier in Research in Microbiology
- Vol. 159 (9-10) , 590-594
Molecular typing and characterization of extended-spectrum TEM, SHV and CTX-M β-lactamases in clinical isolates of Enterobacter cloacae
- 1 November 2008
- Published by Elsevier in Research in Microbiology
- Vol. 159 (9-10) , 590-594
Molecular typing and characterization of extended-spectrum TEM, SHV and CTX-M β-lactamases in clinical isolates of Enterobacter cloacae
- 1 March 2008
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 46 (3) , 1037-1044
Successive Emergence of Extended-Spectrum β-Lactamase-Producing and Carbapenemase-Producing Enterobacter aerogenes Isolates in a University Hospital
Sixty-two clinical isolates of Enterobacter aerogenes resistant to expanded-spectrum cephalosporins were collected between July 2003 and May 2005. Among these isolates, 23 (37.1%) were imipenem (IPM) susceptible, and 39 (62.9%) were IPM insusceptible, of which 89.7% (35/39) were resistant and 10.3% (4/39) were intermediate. Isolate genotypes were compared by pulsed-field gel electrophoresis. Of 62 isolates, 48 belonged to epidemic pulsotype A (77.4%). This pulsotype included 37.5% and 58.4% of β-lactam phenotypes b and a, respectively. Nine isolates (14.5%) belonged to pulsotype E, which included 22.3% and 77.7% of phenotypes b and a, respectively. The β-lactamases with pIs of 5.4, 6.5, 8.2, and 8.2 corresponded to extended-spectrum β-lactamases (ESBLs) TEM-20, TEM-24, SHV-5, and SHV-12, respectively. Of 39 IPM-insusceptible E. aerogenes isolates, 26 (66.6%) were determined to be metallo-β-lactamase producers, by using a phenotypic method. Of these isolates, 24 harbored a bla IMP-1 gene encoding a protein with a pI of >9.5, and two carried the bla VIM-2 gene encoding a protein with a pI of 5.3, corresponding to β-lactamases IMP-1 and VIM-2, respectively. The remaining 13 (33.4%) isolates were negative for the bla IMP-1 and bla VIM-2 genes but showed an alteration of their outer membrane proteins (OMPs). Ten of these isolates produced the two possible OMPs (32 and 42 kDa), with IPM MICs between 8 and 32 μg/ml, and three others produced only a 32-kDa OMP with IPM MICs >32 μg/ml. This work demonstrates that, in addition to resistance to expanded-spectrum cephalosporins, IPM resistance can occur in ESBL-producing E. aerogenes isolates by carbapenemase production or by the loss of porin in the outer membrane.
- 1 March 2008
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 46 (3) , 1037-1044
Successive Emergence of Extended-Spectrum β-Lactamase-Producing and Carbapenemase-Producing Enterobacter aerogenes Isolates in a University Hospital
Sixty-two clinical isolates of Enterobacter aerogenes resistant to expanded-spectrum cephalosporins were collected between July 2003 and May 2005. Among these isolates, 23 (37.1%) were imipenem (IPM) susceptible, and 39 (62.9%) were IPM insusceptible, of which 89.7% (35/39) were resistant and 10.3% (4/39) were intermediate. Isolate genotypes were compared by pulsed-field gel electrophoresis. Of 62 isolates, 48 belonged to epidemic pulsotype A (77.4%). This pulsotype included 37.5% and 58.4% of β-lactam phenotypes b and a, respectively. Nine isolates (14.5%) belonged to pulsotype E, which included 22.3% and 77.7% of phenotypes b and a, respectively. The β-lactamases with pIs of 5.4, 6.5, 8.2, and 8.2 corresponded to extended-spectrum β-lactamases (ESBLs) TEM-20, TEM-24, SHV-5, and SHV-12, respectively. Of 39 IPM-insusceptible E. aerogenes isolates, 26 (66.6%) were determined to be metallo-β-lactamase producers, by using a phenotypic method. Of these isolates, 24 harbored a bla IMP-1 gene encoding a protein with a pI of >9.5, and two carried the bla VIM-2 gene encoding a protein with a pI of 5.3, corresponding to β-lactamases IMP-1 and VIM-2, respectively. The remaining 13 (33.4%) isolates were negative for the bla IMP-1 and bla VIM-2 genes but showed an alteration of their outer membrane proteins (OMPs). Ten of these isolates produced the two possible OMPs (32 and 42 kDa), with IPM MICs between 8 and 32 μg/ml, and three others produced only a 32-kDa OMP with IPM MICs >32 μg/ml. This work demonstrates that, in addition to resistance to expanded-spectrum cephalosporins, IPM resistance can occur in ESBL-producing E. aerogenes isolates by carbapenemase production or by the loss of porin in the outer membrane.
- 30 September 2005
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 26 (3) , 219-229
Molecular characterisation and mechanisms of resistance of multidrug-resistant human Salmonella enterica serovar Typhimurium isolated in Amiens (France)
- 30 September 2005
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 26 (3) , 219-229
Molecular characterisation and mechanisms of resistance of multidrug-resistant human Salmonella enterica serovar Typhimurium isolated in Amiens (France)
- Open Access
- 1 May 2005
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 11 (5) , 395-401
Molecular diversity of Proteus mirabilis isolates producing extended-spectrum β-lactamases in a French university hospital
- 1 May 2005
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 11 (5) , 395-401
Open AccessMolecular diversity of Proteus mirabilis isolates producing extended-spectrum β-lactamases in a French university hospital
- 1 January 2003
- Published by Elsevier in International Journal of Medical Microbiology
- Vol. 293 (2-3) , 219-223
Molecular epidemiology of ampicillin-resistant clinical isolates of Salmonella enterica serovar Typhimurium
- 1 January 2003
- Published by Elsevier in International Journal of Medical Microbiology
- Vol. 293 (2-3) , 219-223
Molecular epidemiology of ampicillin-resistant clinical isolates of Salmonella enterica serovar Typhimurium